Northwest Bancshares heads into its Q1 2026 earnings call today with a notably quiet short market and a stock that has quietly outperformed its peer group.
The most striking feature of the positioning is how quickly bears have pulled back. Short interest dropped nearly 9% in a single session on April 24, and is down more than 9% on the week. At 3.9% of the free float, it remains low and is heading lower — a far cry from the 52-week utilization peak of 9.07%, which reflected a substantially more contested lending market. Today, only 3.65% of available borrow has been used, near the bottom of the recent range. Borrowing costs have also fallen sharply, down roughly 22% over the past month to 0.36% APR — barely above the floor. Options sentiment echoes the same lack of aggression: the put/call ratio is 0.18, only a fraction of a standard deviation above its 20-day mean of 0.17, and sitting near a 52-week low. There is simply no hedging pressure visible ahead of the print.
The stock itself has moved against its peers. NWBI gained 1.6% on Monday and is up more than 8.6% over the past month, reaching $13.49. Closest correlates have moved in the opposite direction: PEBO fell 1.4% on the day, dropped 1.1%, and was off by a similar margin. was among the hardest hit in the peer group, declining over 4.5% on Monday and more than 5% on the week. NWBI's relative resilience is notable — it has quietly added over 10% year-to-date while several comparable regional banks have struggled.
The analyst backdrop offers limited guidance, as no meaningful rating changes have emerged within the past month. Coverage is sparse and clustered around neutral to hold. DA Davidson maintained a Neutral rating with a $13.00 target as recently as late January. Piper Sandler assumed coverage in December with the same stance. Truist initiated at Buy with a $15.00 target back in October — the sole outlier that points to material upside from the current $13.49. The consensus mean price target is $13.86, implying only about 2.7% upside, which places the stock close to where the Street thinks fair value lies. At roughly 10x trailing earnings and a price-to-book near 0.99, the valuation is modest by regional bank standards, offering income investors a forward dividend yield of around 6%. The dividend score ranks in the 69th percentile of the broader universe. Forward EPS momentum, however, is only middling — the 12-month forward estimate improvement sits in the 66th percentile — keeping the earnings quality narrative unresolved.
The print today will test whether the revenue and net income trajectory — ORTEX estimates point to $717 million in revenue and $194 million in net income for the period — justifies the stock's quiet outperformance of peers, and whether management's commentary on credit quality and margin pressure in a still-uncertain rate environment can sustain a valuation that has crept back toward book value.
See the live data behind this article on ORTEX.
Open NWBI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
